那不勒斯得分:为接受新辅助化疗的乳腺癌患者提供了一种新的预后生物标志物
Yuting Xiu1, Cong Jiang1, Qinghua Huang2
1Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150086, China.
Journal of cancer research and clinical oncology
|September 12, 2023
概括
那不勒斯评分 (NPS) 是乳腺癌患者接受新辅助化疗 (NAC) 的新预后工具. 它有效地预测整体存活率 (OS) 和无病存活率 (DFS),优于传统分期方法.
科学领域:
- 在瘤学瘤学.
- 癌症预后 癌症预后
- 化疗研究 化疗研究
背景情况:
- 那不勒斯得分 (NPS) 是各种癌症的新兴预后指标.
- 它在接受新辅助化疗 (NAC) 的乳腺癌患者中的实用性仍然未被探索.
研究的目的:
- 在接受NAC.的乳腺癌患者中调查那不勒斯得分 (NPS) 的预后价值.
- 评估NPS与整体存活率 (OS) 和无病存活率 (DFS) 之间的关系.
主要方法:
- 对217名接受NAC.治疗的乳腺癌患者的回顾性分析.
- 卡普兰-梅尔生存曲线和对OS和DFS的日志等级测试.
- 考克斯回归和诺莫格拉姆开发用于预后预测,内部验证.
主要成果:
- NPS与患者年龄有显著的相关性.
- 较低的NPS得分与显著更高的5年OS和DFS率有关.
- 开发的名图表显示了OS (AUC=0.728) 和DFS (AUC=0.630) 的良好预测性能.
结论:
- 那不勒斯评分 (NPS) 是乳腺癌患者在NAC后的新预后指标.
- 将NPS与临床病理特征相结合,可以提高超越传统TNM分期的预测准确性.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
190
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
190
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381


